Latest News Archive
Please select Category, Year, and then Month to display items
27 September 2018
Photo Varsity Sports
Newly capped Protea Khanyisa Chawane will return for the Kovsies on Monday when they face the Maties in the semi-final of Varsity Netball in the Callie Human centre.
A first ever Varsity Netball final in the Callie Human centre lie in what should the Kovsies cross the line this Monday in the semi-final against the Maties in Bloemfontein at 19:00.
Having ended first on the log, the Kovsies will enjoy home court advantage should they progress to the final on 8 October.
The Kovsies won their group fixture against the Maties last month in Stellenbosch by 59-56. It will be the first time the two teams clash in a knock-out match in the competition and also a first visit to the Callie Human centre for the Maties since 2013.
The Kovsies won six out of their seven group matches with their only loss against the Madibaz by a single goal.
They will be strengthened by the return of Khanyisa Chawane (centre) who missed a couple of matches whilst being in Australasia where she made her Protea debut. Meagan Roux, who can either play wing attack or goal attack, is also back. She travelled with the Proteas as a replacement.
They will however be without Tanya Mostert who will be on honeymoon. Her wedding is on Saturday. Remarkable it will only be the second time since her debut in the Kovsies’ very first match in the inaugural competition in 2013 that Mostert will miss a Varsity Netball match.
“The players really yearn to lift that trophy. It’s been some time since we last played in the final (in 2014). My message to them will be to give it their all on Monday,” Mostert said.
According to her the team is currently one that gels very nicely.
“Everyone fully understands their role in the team. We realized where our strengths lie and play according to it. Adding to that we play for one another.”
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”